HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Paul Kurlansky Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kurlansky, P. Search for Related Content PubMed PubMed Citation Articles by Kurlansky, P. Related Collections Coronary disease Related Article

---

Original Articles: Adult Cardiac

Invited Commentary

Florida Heart Research Institute, 4770 Biscayne Blvd, Site 500, Miami, FL 33137

(Email: doctorwu18@aol.com).

The first 20% of the full text of this article appears below.

Despite remarkable advances in interventional and medical therapy during the past 2 decades and a continuing decline in death, cardiovascular disease remains the leading killer in our country, and, increasingly, throughout the world. The current epidemic of obesity sadly promises to erase medical progress. Therefore the question of optimal treatment will remain a lively and hopefully productive debate for years to come.

Provocative studies such as Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) [1] have called into question the value of percutaneous coronary . . . [Full Text of this Article]

Related Article

Changing Volumes, Risk Profiles, and Outcomes of Coronary Artery Bypass Grafting and Percutaneous Coronary Interventions

Gabriel S. Aldea, Nahush A. Mokadam, Rayland Melford, Jr, Douglas Stewart, Charles Maynard, Mark Reisman, and Richard Goss
Ann. Thorac. Surg. 2009 87: 1828-1838. [Abstract] [Full Text] [PDF]